Literature DB >> 2841016

Morphine-induced downregulation of mu-opioid receptors in neonatal rat brain.

A Tempel1, J Habas, W Paredes, G A Barr.   

Abstract

Chronic administration of morphine to pre- and postnatal rats produced a marked decrease in brain mu-opioid receptor density with-out change in receptor affinity. No significant changes in delta- or kappa-receptors were observed. This downregulation was accompanied by tolerance to the analgesic actions of morphine. In neonates exposed to morphine from postnatal day one, mu-receptor number was significantly depressed until postnatal day 8, then increased gradually to control levels by day 14 of treatment. Longer treatment produced no further change in opioid receptors. These data represent the first demonstration of in vivo downregulation of brain mu-opioid receptors following morphine administration and provide evidence for a unique plasticity of the immature opioid receptor system.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2841016     DOI: 10.1016/0165-3806(88)90176-9

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  14 in total

1.  kappa-Opioid agonist modulation of [3H]thymidine incorporation into DNA: evidence for the involvement of pertussis toxin-sensitive G protein-coupled phosphoinositide turnover.

Authors:  J Barg; M M Belcheva; J Rowiński; C J Coscia
Journal:  J Neurochem       Date:  1993-04       Impact factor: 5.372

2.  Ontogenetic studies of tolerance development: effects of chronic morphine on the hypothalamic-pituitary-adrenal axis.

Authors:  P J Little; C M Kuhn
Journal:  Psychopharmacology (Berl)       Date:  1995-11       Impact factor: 4.530

3.  Regulation of opioid tolerance by let-7 family microRNA targeting the mu opioid receptor.

Authors:  Ying He; Cheng Yang; Chelsea M Kirkmire; Zaijie Jim Wang
Journal:  J Neurosci       Date:  2010-07-28       Impact factor: 6.167

Review 4.  Changing mechanisms of opiate tolerance and withdrawal during early development: animal models of the human experience.

Authors:  Gordon A Barr; Anika McPhie-Lalmansingh; Jessica Perez; Michelle Riley
Journal:  ILAR J       Date:  2011

5.  Chronic intrathecal morphine treatment does not cause down-regulation of spinal adenosine A1 receptors in rats.

Authors:  P L Tao; C S Wong; M C Lin
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-07       Impact factor: 3.000

6.  Differential down- and up-regulation of rat brain opioid receptor types and subtypes by buprenorphine.

Authors:  M M Belcheva; J Barg; R J McHale; S Dawn; M T Ho; E Ignatova; C J Coscia
Journal:  Mol Pharmacol       Date:  1993-07       Impact factor: 4.436

7.  Morphine actions on supraoptic oxytocin neurones in anaesthetized rats: tolerance after i.c.v. morphine infusion.

Authors:  K M Pumford; G Leng; J A Russell
Journal:  J Physiol       Date:  1991       Impact factor: 5.182

8.  The interaction of the mu-opioid receptor and G protein is altered after chronic morphine treatment in rats.

Authors:  P L Tao; C R Lee; P Y Law; H H Loh
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-11       Impact factor: 3.000

9.  Early life adversity as a risk factor for fibromyalgia in later life.

Authors:  Lucie A Low; Petra Schweinhardt
Journal:  Pain Res Treat       Date:  2011-10-12

10.  Let-7 microRNAs and Opioid Tolerance.

Authors:  Ying He; Zaijie Jim Wang
Journal:  Front Genet       Date:  2012-06-21       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.